| Followers | 54 |
| Posts | 6684 |
| Boards Moderated | 0 |
| Alias Born | 01/11/2017 |
Tuesday, August 01, 2023 7:36:15 PM
I appreciate the sentiments. Whether GBM or other cancers, I don’t know of anyone who’s not been personally affected.
I was very bullish on this company back when I started my first position then brought some others in. This was well before data lock and had 400k+ shares in the $.30 range. I’ve bought up and down when the fluctuations happened. Overall I’ve made more money buying/selling on the dips and rips. This week I bought 60k+ shares at $.53. Stunningly, I’m in the red.
At some point, management will need to own this process. I believe and manage under the philosophy of “Extreme Ownership”. Linda, et al is the exact opposite. It is literally everybody else’s fault:
Adam F
Naked shorts
BP
Spoofers
If the goal is to get the drug to market, partner with a BP that has the resources and infrastructure to get this drug fast tracked. There is little communication, too much emphasis on extraneous milestones that the market doesn’t value. Case in point:
TLD was great
JA was great
PR was great
Lawsuit pending
Why is this $.52? Are the spoofers still spoofing? When is the last time the CEO got up on a stage, ala Steve Jobs, and told her shareholders the state of the company.
All of these bad actors would have a harder time drumming up bullshit when the CEO gives a full-throated update on where the company is at.
One thing I’ve learned is that in the absence of information, people will create their own. I hope I’ve given you an appropriate response to an appropriate question.
Have a great day! I’m rooting for you
I was very bullish on this company back when I started my first position then brought some others in. This was well before data lock and had 400k+ shares in the $.30 range. I’ve bought up and down when the fluctuations happened. Overall I’ve made more money buying/selling on the dips and rips. This week I bought 60k+ shares at $.53. Stunningly, I’m in the red.
At some point, management will need to own this process. I believe and manage under the philosophy of “Extreme Ownership”. Linda, et al is the exact opposite. It is literally everybody else’s fault:
Adam F
Naked shorts
BP
Spoofers
If the goal is to get the drug to market, partner with a BP that has the resources and infrastructure to get this drug fast tracked. There is little communication, too much emphasis on extraneous milestones that the market doesn’t value. Case in point:
TLD was great
JA was great
PR was great
Lawsuit pending
Why is this $.52? Are the spoofers still spoofing? When is the last time the CEO got up on a stage, ala Steve Jobs, and told her shareholders the state of the company.
All of these bad actors would have a harder time drumming up bullshit when the CEO gives a full-throated update on where the company is at.
One thing I’ve learned is that in the absence of information, people will create their own. I hope I’ve given you an appropriate response to an appropriate question.
Have a great day! I’m rooting for you
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
